A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  New England Journal of Medicine

• Publication date

  2003-03-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJMOA025217PMID 12660384
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical resistance to the kinase inhibitor STI-571 in chronic myeloid leukemia by mutation of Tyr-253 in the Abl kinase domain P-loop

  2002cited by this paper
• Treatment of hypereosinophilic syndrome with imatinib mesilate.

  2002cited by this paper
• Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

  2002cited by this paper
• Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia.

  2002cited by this paper
• Evidence for position effects as a variant ETV6-mediated leukemogenic mechanism in myeloid leukemias with a t(4;12)(q11-q12;p13) or t(5;12)(q31;p13).

  2002cited by this paper
• Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.

  2002cited by this paper
• Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.

  2001cited by this paper
• STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications

  2001cited by this paper
• Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.

  2001cited by this paper
• H4(D10S170), a gene frequently rearranged in papillary thyroid carcinoma, is fused to the platelet-derived growth factor receptor beta gene in atypical chronic myeloid leukemia with t(5;10)(q33;q22).

  2001cited by this paper
• Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification

  2001cited by this paper
• Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors.

  2000cited by this paper
• Clonality of isolated eosinophils in the hypereosinophilic syndrome.

  1999cited by this paper
• Fusion of a novel gene, BTL, to ETV6 in acute myeloid leukemias with a t(4;12)(q11-q12;p13).

  1999cited by this paper
• Transformation of hematopoietic cell lines to growth‐factor independence and induction of a fatal myelo‐ and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes

  1998cited by this paper
• Fusion of Huntingtin Interacting Protein 1 to Platelet-Derived Growth Factor β Receptor (PDGFβR) in Chronic Myelomonocytic Leukemia With t(5;7)(q33;q11.2)

  1998cited by this paper
• Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2).

  1998cited by this paper
• Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia.

  1997cited by this paper
• Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reaction.

  1997cited by this paper
• CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins.

  1997cited by this paper
• Rapid Molecular Cloning of Rearrangements of the IGHJ Locus Using Long- Distance Inverse Polymerase Chain Reaction

  1997cited by this paper
• Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative.

  1996cited by this paper
• Successful use of the same slide for consecutive fluorescence in situ hybridization experiments

  1996cited by this paper
• The idiopathic hypereosinophilic syndrome.

  1996cited by this paper
• Structure, organization, and transcription units of the human alpha-platelet-derived growth factor receptor gene, PDGFRA.

  1995cited by this paper
• The FIP1 gene encodes a component of a yeast pre-mRNA polyadenylation factor that directly interacts with poly(A) polymerase.

  1995cited by this paper
• Clonal nature of hypereosinophilic syndrome.

  1994cited by this paper
• Clonal nature of hypereosinophilic syndrome [letter]

  1994cited by this paper
• The idiopathic hypereosinophilic syndrome.

  1994cited by this paper
• Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation.

  1994cited by this paper
• A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia

  1982cited by this paper
• THE HYPEREOSINOPHILIC SYNDROME: Analysis of Fourteen Cases With Review of The Literature

  1975cited by this paper

• Differential Diagnosis of Eosinophilic Lung Diseases.

  2026cites this paper
• Case Report: Co-existence of BCR::PDGFRA gene fusion and PDGFRA variants in myeloid neoplasm with persistent leukocytosis, large splenomegaly, and eosinophilia.

  2026cites this paper
• Development and validation of the FIP-Score for the screening of FIP1L1::PDGFRA-associated hypereosinophilic syndrome.

  2025cites this paper
• Idiopathic Hypereosinophilic Syndrome Presenting As Eosinophilic Ascites and Pleural Effusion in an Elderly Male: A Rare Clinical Manifestation

  2025cites this paper
• Durable complete remission with imatinib monotherapy in a patient with FIP1L1-PDGFRA rearranged myeloid neoplasm with extramedullary involvement

  2025cites this paper
• A rare case of variant acute promyelocytic leukemia with FIP1L1-RARA fusion gene: case report and literature review

  2025cites this paper
• Hypereosinophilia: Clinical Presentations and Diagnostic Distinction between Syndromic and Reactive Entities – A Case Series

  2025cites this paper
• 以Löeffler心内膜炎为主要临床特征的嗜酸性粒细胞增多症6例临床分析

  2025cites this paper
• Imatinib Treatment in Primary Acute Basophilic Leukemia with FIP1L1-PDGFRα Rearrangement: A Case Report.

  2025cites this paper
• Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusion: report of two cases with different clinical presentation

  2025cites this paper
• Hypereosinophilia in Children

  2025cites this paper
• Head and Neck Classic Hodgkin, T and NK Lymphomas with Eosinophilia

  2025cites this paper
• Ruxolitinib targets JAK-STAT signaling to modulate neutrophil activation in refractory macrophage activation syndrome

  2025cites this paper
• Clonal eosinophilia with exclusive pulmonary involvement driven by PDGFRA rearrangement treated with imatinib: A case report

  2025cites this paper
• PDGFRα/β heterodimer activation negatively affects downstream ERK1/2 signaling and cellular proliferation

  2025cites this paper
• Rare Genetic and Uncommon Morphological Entities in Adults with Acute Myeloid Leukemia

  2025cites this paper
• Four challenging cases of eosinophilic endocarditis or myocarditis with literature review

  2025cites this paper
• Loffler endocarditis as an initial manifestation of lung adenocarcinoma: A case report

  2025cites this paper
• Identification of a novel NRF1::PDGFRA fusion in myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions

  2025cites this paper
• Long read nanopore DNA sequencing with adaptive sampling to identify tyrosine kinase fusion genes

  2025cites this paper
• Loeffler endocarditis revealing chronic eosinophilic leukaemia with FIP1L1-PDGFRA rearrangement: a case report

  2025cites this paper
• Eosinophilic Cardiac Involvement.

  2025cites this paper
• Overcoming the sorafenib resistance mechanism in FLT3-mutated acute myeloid leukemia: molecular basis and new targets

  2025cites this paper
• Long-term Efficacy and Safety of Benralizumab Treatment for PDGFRA-negative Hypereosinophilic Syndrome.

  2025cites this paper
• A newly identified pathology of episodic angioedema with hypereosinophilia (Gleich syndrome) revealed by nultiomics analysis

  2025cites this paper
• Comparative Analysis of Targeted RNA-Seq and Optical Genome Mapping for Detecting Gene Rearrangements in Acute Leukemia

  2025cites this paper
• A cutaneous spindle cell neoplasm characterized by a COL3A1::PDGFRA fusion

  2024cites this paper
• Prognostic factors of idiopathic hypereosinophilic syndrome: A nationwide survey in Japan

  2024cites this paper
• Multiple allostery in the regulation of PDGFR beta kinase activities

  2024cites this paper
• Imatinib is effective in some PDGFRA/B‐negative hypereosinophilic syndromes: A step closer to unveiling underlying mechanisms

  2024cites this paper
• In-Depth Review of Loeffler Endocarditis: What Have We Learned?

  2024cites this paper
• Severe heart failure and intracardiac thrombosis: going beyond the appearance for diagnosis and treatments.

  2024cites this paper
• 5TH EDITION OF THE WORLD HEALTH ORGANIZATION CLASSIFICATION OF TUMORS OF THE HEMATOPOIETIC AND LYMPHOID TISSUES.

  2024cites this paper
• Establishment and characterization of NCC-DFSP5-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line

  2024cites this paper
• The unexpected and unresolved roles of PDGFRA and PDGFRB in T-cell acute lymphoblastic leukemia

  2024cites this paper
• When Blood Cell Counts Matter: Hypereosinophilic Syndrome as a Rare Cause of Ischemic Strokes

  2024cites this paper
• Modulation of diverse biological processes by CPSF, the master regulator of mRNA 3′ ends

  2024cites this paper
• Incessant Ventricular Tachycardia

  2024cites this paper
• Approach to Acute Myeloid Leukemia with Increased Eosinophils and Basophils

  2024cites this paper
• Intra- and inter-patient diversity in hepatocellular carcinoma based on phosphorylation profiles-A pilot study in a single institution.

  2024cites this paper
• Phase II trial of imatinib mesylate in patients with PDGFRA/B‐negative hypereosinophilic syndrome

  2024influential citation
• Chronic eosinophilic leukaemia—Not otherwise specified: Clinical features, genomic insight and therapeutic strategies

  2024cites this paper
• Eosinophilia in Rheumatology: A Management Challenge

  2024cites this paper
• World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management

  2024influential citation
• Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)

  2024cites this paper
• Prostate cancer subtyping and differential methylation analysis based on the ETS family of transcription factors fusion genes

  2024cites this paper
• How I (Diagnose and) Treat Myeloid / Lymphoid Neoplasms with Tyrosine Kinase Gene Fusions.

  2024cites this paper
• Integration of genomic sequencing drives therapeutic targeting of PDGFRA in T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.

  2023cites this paper
• Endomyocardiofibrosis in the Americas Collaborative Study: The EMF-SIAC registry: Endomyocardiofibrosis in the Americas.

  2023cites this paper
• Promoter swapping of truncated PDGFRB drives Ph-like acute lymphoblastic leukemia

  2023cites this paper
• HES and EGPA: Two Sides of the Same Coin.

  2023cites this paper
• Unmet needs and evidence gaps in hypereosinophilic syndrome and eosinophilic granulomatosis with polyangiitis.

  2023cites this paper
• French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes

  2023cites this paper
• The dermatologic and histologic spectrum of hypereosinophilic syndrome

  2023cites this paper
• Mepolizumab therapy improves the most bothersome symptoms in patients with hypereosinophilic syndrome

  2023cites this paper
• Case of cryptic TNIP1::PDGFRB rearrangement presenting with myelodysplastic syndrome achieved hematologic and cytogenetic remission with low-dose imatinib plus decitabine therapy

  2023cites this paper
• Inflammatory fibroid polyp: A series of 29 cases and a systematic review of the literature

  2023cites this paper
• Myeloische/lymphatische Neoplasien mit Eosinophilie und Tyrosinkinase-Fusionsgenen

  2023cites this paper
• Laboratory Workup of Hypereosinophilia

  2023cites this paper
• Gatekeeper mutations activate FGF receptor tyrosine kinases by destabilizing the autoinhibited state

  2023cites this paper
• Endomyocardial fibrosis: a tragic conundrum or a mere negligence?

  2023cites this paper
• Rapid LC-MS/MS Bosutinib Quantification with Applications in Metabolic Stability Estimation

  2023cites this paper
• Cost of Treatment for Myelofibrosis Patients in Ministry of Health Hospitals in Sarawak, Malaysia

  2023cites this paper
• Novel FIP1L1::KIT fusion in a myeloid neoplasm with eosinophilia, T-lymphoblastic transformation, and dasatinib response

  2023cites this paper
• Case Report: A Rare Case of Eosinophilic Ureteritis in a Woman with Reccuring Bilateral Ureteric Strictures causing Hydroureteronephrosis

  2023cites this paper
• False-Negative Testing for FIP1L1::PDGFRA by Fluorescence in situ Hybridization Is a Frequent Cause of Diagnostic Delay

  2023cites this paper
• Revisiting a case of idiopathic hypereosinophilic syndrome with novel molecular techniques identifies a second case of a myeloid/lymphoid neoplasm with a SART3::PDGFRB fusion

  2023influential citation
• Eosinophils—from cradle to grave

  2023cites this paper
• Development and Validation of an Ecofriendly, Rapid, Simple and Sensitive UPLC-MS/MS Method for Entrectinib Quantification in Plasma for Therapeutic Drug Monitoring

  2023cites this paper
• FIP1L1::PDGFRA fusion driving three synchronous haematological malignancies.

  2023cites this paper
• Metanephric stromal tumor in an adult with PDGFRA mutation: a case report

  2023cites this paper
• When eosinophilic inflammation extends beyond allergy

  2023cites this paper
• The Case | Hypereosinophilia in a hemodialysis patient.

  2022cites this paper
• Signaling by PDGFR in disease

  2022cites this paper
• Myeloproliferative neoplasm with basophilia and abnormality of platelet-derived growth factor receptor a translocation: a case report

  2022cites this paper
• Aberrant Expression of miR-1301 in Human Cancer

  2022cites this paper
• Eosinophils and eosinophilic immune dysfunction in health and disease

  2022cites this paper
• Pancarditis as the Clinical Presentation of Eosinophilic Granulomatosis with Polyangiitis: A Multimodality Approach to Diagnosis

  2022cites this paper
• Hypereosinophilic syndromes and lung involvement

  2022cites this paper
• Application of HRM Analysis in Detection of PDGFRA Exon 10 Polymorphism in CML Patients with Imatinib Resistance

  2022cites this paper
• An intriguing case of a paravertebral extramedullary erythropoiesis presenting as tumor‐mimicking lesion in a patient with eosinophilia with FIP1L1‐PDGFRA rearrangement

  2022cites this paper
• Available and emerging therapies for bona fide advanced systemic mastocytosis and primary eosinophilic neoplasms.

  2022cites this paper
• Eosinophile Pneumonien und hypereosinophiles Syndrom

  2022cites this paper
• Morphology and clinical characteristics of a case of FIP1L1-RARA fusion-associated variant acute promyelocytic leukemia

  2022cites this paper
• Case Report: Pediatric myeloid/lymphoid neoplasm with eosinophilia and PDGFRA rearrangement: The first case presenting as B-lymphoblastic lymphoma

  2022cites this paper
• Whole-genome optical mapping to elucidate myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions.

  2022cites this paper
• FIP1L1‐PDGFRA fusion gene in T‐lymphoblastic lymphoma: A case report

  2022cites this paper
• Eosinophilic granulomatosis with polyangiitis: A review.

  2022cites this paper
• Genomics of PDGFR-rearranged hypereosinophilic syndrome

  2022cites this paper
• Biologic therapies for hypereosinophilic disorders: From tyrosine kinase inhibitors to monoclonal antibodies. Towards an increasingly customized management?

  2022cites this paper
• Partial tandem duplication of KMT2A gene in patient afflicted with hypereosinophilic syndrome: A case report.

  2022cites this paper
• Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes

  2022cites this paper
• Does the use of the Bruton Tyrosine Kinase inhibitors and the c-kit inhibitor masitinib result in clinically significant outcomes among patients with various forms of multiple sclerosis?

  2022cites this paper
• Quantitative Cell Proteomic Atlas: Pathway-scale targeted mass spectrometry for high-resolution functional profiling of cell signaling

  2022cites this paper
• Two pediatric oncologic cases of hypereosinophilic syndrome and review of the literature

  2022cites this paper
• A Unique Case of Cardiac Hypereosinophilia With Recurrent Valve Thrombosis After Mechanical Mitral Valve Replacement in the Setting of a Supratherapeutic International Normalized Ratio

  2022cites this paper
• Chronic Eosinophilic Leukemia Presenting as Cardiac Failure

  2022cites this paper
• CD3-CD4+ Lymphocytic Variant Hypereosinophilic Syndrome: Diagnostic Tools Revisited.

  2021cites this paper
• Inhibition of KIT Tyrosine Kinase Activity: Two Decades After the First Approval.

  2021cites this paper
• Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies.

  2021cites this paper